SEC Filings

Filing date	Description	Form	Filing Group	Issuer	View
View HTML nc10001281x1_EIDOS_Annual Report 2018_E-bookproof_v2.pdf 3 MB 0001564590-19-011575.rtf 0001564590-19-011575.xls EX-101.INS - XBRL INSTANCE DOCUMENT	Apr 15, 2019	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	Eidos Therapeutics, Inc.
View HTML 0001564590-20-006823.pdf 0001564590-20-006823.rtf 0001564590-20-006823.xls EX-101.INS - XBRL INSTANCE DOCUMENT	Feb 26, 2020	Annual report which provides a comprehensive overview of the company for the past year	10-K	Annual Filings	Eidos Therapeutics, Inc.
View HTML 0001564590-18-019988.pdf 0001564590-18-019988.rtf 0001564590-18-019988.xls EX-101.INS - XBRL INSTANCE DOCUMENT	Aug 07, 2018	Quarterly report which provides a continuing view of a company's financial position	10-Q	Quarterly Filings	Eidos Therapeutics, Inc.
View HTML 0001564590-18-027464.pdf 0001564590-18-027464.rtf 0001564590-18-027464.xls EX-101.INS - XBRL INSTANCE DOCUMENT	Nov 06, 2018	Quarterly report which provides a continuing view of a company's financial position	10-Q	Quarterly Filings	Eidos Therapeutics, Inc.
View HTML 0001564590-19-016564.pdf 0001564590-19-016564.rtf 0001564590-19-016564.xls EX-101.INS - XBRL INSTANCE DOCUMENT	May 07, 2019	Quarterly report which provides a continuing view of a company's financial position	10-Q	Quarterly Filings	Eidos Therapeutics, Inc.
View HTML 0001564590-19-027996.pdf 0001564590-19-027996.rtf 0001564590-19-027996.xls EX-101.INS - XBRL INSTANCE DOCUMENT	Aug 01, 2019	Quarterly report which provides a continuing view of a company's financial position	10-Q	Quarterly Filings	Eidos Therapeutics, Inc.
View HTML 0001564590-19-039169.pdf 0001564590-19-039169.rtf 0001564590-19-039169.xls EX-101.INS - XBRL INSTANCE DOCUMENT	Oct 31, 2019	Quarterly report which provides a continuing view of a company's financial position	10-Q	Quarterly Filings	Eidos Therapeutics, Inc.
View HTML 0001564590-20-023604.pdf 0001564590-20-023604.rtf 0001564590-20-023604.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA	May 08, 2020	Quarterly report which provides a continuing view of a company's financial position	10-Q	Quarterly Filings	Eidos Therapeutics, Inc.
View HTML 0001564590-20-037814.pdf 0001564590-20-037814.rtf 0001564590-20-037814.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA	Aug 06, 2020	Quarterly report which provides a continuing view of a company's financial position	10-Q	Quarterly Filings	Eidos Therapeutics, Inc.
View HTML 0001564590-20-048909.pdf 0001564590-20-048909.rtf 0001564590-20-048909.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA	Oct 29, 2020	Quarterly report which provides a continuing view of a company's financial position	10-Q	Quarterly Filings	Eidos Therapeutics, Inc.

Data provided by Kaleidoscope.